The Latest

‍The Large and Growing MarketHealthcare is undergoing a paradigm shift. With rising chronic diseases, escalating healthcare costs, and growing dissatisfaction with conventional treatments, patients are turning to Complementary and Alternative Medicine (CAM). CAM is no longer seen as fringe medicine. It is now a mainstream movement, with increasing adoption in hospitals, clinics, and even corporate wellness programs. Over 50% of U.S. physicians recommended at least one complementary health approach to their patients within a 12-month period. 1One-third of Americans use CAM alongside conventional treatments. In Europe, 25-50% of the population uses CAM therapies, including homeopathy, naturopathy, and herbal medicine. In Asia, Traditional Chinese Medicine (TCM) and Ayurveda are deeply embedded in cultural and medical systems. 2The Global CAM Market is valued at $100–$400 billion, with a projected growth rate of 15–25%. The U.S. CAM market is valued at over $50 billion 3. Factors driving this growth include:Patients are more proactive about their health.More people are seeking alternative solutions for pain, inflammation, and metabolic disorders.CAM aligns with the booming self-care, fitness, and mental health movements.AI-powered health platforms, wearable biofeedback devices, and personalized wellness programs are making CAM more accessible.Major corporations, insurance providers, and even governments are beginning to integrate CAM into healthcare policies and benefits. 4True healthcare innovation lies in integration — combining the best of conventional medicine with evidence-based CAM therapies.Chronic Disease Management: CAM therapies like acupuncture, herbal medicine, and functional nutrition help manage diabetes, cardiovascular diseases, and autoimmune disorders without heavy reliance on pharmaceuticals.Pain & Opioid Crisis Solutions: Chiropractic care, acupuncture, and red light therapy offer non-drug alternatives for pain management, reducing opioid dependence.Mental Health & Stress Reduction: Meditation, breathwork, and biofeedback therapies help treat anxiety, depression, PTSD, and insomnia — often as effectively as medication.Personalized & Preventive Healthcare: Functional and integrative medicine focus on root causes rather than symptom suppression, reducing long-term healthcare costs.Patient Demand & Market Trends: Hospitals and clinics adopting CAM see higher patient satisfaction, improved treatment outcomes, and increased revenue. 5Several world-renowned institutions, such as Mayo Clinic, Cleveland Clinic, and Johns Hopkins, have already integrated CAM into their healthcare offerings—proving that a blended approach is the future of medicine.RegenMed Is Strongly Positioned To BenefitThere is very little data on integrative, complementary, or alternative medicine procedures. Circles represent a clinical grade yet low-cost approach to generating statistically significant datasets for any individual or combination of procedures. RegenMed is already working with doctors around the world in developing such datasets. They will be critical to:Regulation & Standardization: Governments are creating guidelines to ensure CAM therapies meet safety and efficacy standards.Insurance Expansion: More insurance companies are covering CAM services, recognizing their cost-effectiveness.AI & Digital CAM Platforms: Personalized health recommendations using AI-driven diagnostics.Mainstream Adoption of Holistic Wellness: Corporations are investing in employee wellness programs that integrate CAM.Psychedelic-Assisted Therapy: Psilocybin and MDMA treatments are gaining momentum for mental health breakthroughs.‍‍

Nate Anderson will interview Michael Tierney, Co-Founder and CEO, as well as Dolph Courchaine, Chief Information and Technology Officer.Topics will include:Market dynamicsCompetitive positioningValuation models Open Q & A sessionAnd more‍Date: Tuesday, February 18Time: 6:30 PM EST‍This campaign closes on March 6.Claim Your Place!

Effective February 10, the U.S. government will cut medical research grants by at least $4 billion. This is only one part of an accelerating trend in reducing healthcare expenditures – often by utilizing modern technology. The National Institutes of Health provide funding to thousands of hospitals, medical schools, universities, and independent research organizations. They in turn support more than 300,000 researchers. In many cases, medical science can advance only through expensive laboratories, hundreds of researchers, and associated overhead. In many more cases however, true improvement in healthcare results from letting physicians not researchers lead the way. In other words, the most impactful clinical research is usually developed from the bottom up, not the top down. Today, as in the past, practicing physicians can generate the best informed and therefore most impactful clinical hypotheses. Physicians are an immensely valuable resource which our current approach to medical research fails to utilize. Even in large academic medical institutions, there is a broad divide between research and everyday clinical practice. This is one more reason America spends far more than any other country on healthcare, with generally worse results. RegenMed provides the technical platforms and burden-free processes allowing physicians in any specialty, wherever located, to collaborate on medical research. Medical research which is statistically significant, and can have a positive and broad impact today. Critically, RegenMed delivers these capabilities to physicians and partnering scientists at a far lower price, and with far less burden, than current approaches. It is thus in a strong position to help healthcare institutions deliver genuine value-based medicine.

We thank all of our individual and institutional investors for their support during this fundraising round. We believe we are now well positioned to accelerate our market traction, and will be closing this investment round ahead of schedule on March 6, 2025.As indicated in our updates on this page, we are excited about our opportunities in 2025. We will continue to post further updates here through March 6. This will include the scheduling for a final Investors Webinar. You may also follow us through our Latest and corporate LinkedIn pages.

Our Broken Healthcare System Is Letting All Of Us DownA large majority of Americans have lost faith in their healthcare system. 1 Seventy percent of physicians and medical students believe that consolidation in healthcare negatively affects patient access to high-quality, cost-effective care. Fundamental problems include:The U.S. spends much more per capita on healthcare than any other country, yet ranks towards the bottom of developed countries in many healthcare metrics. 2Over 21% of U.S. children aged 6–17 are obese. In Japan, the number is about 3%. 395% of medical spending comes after someone gets sick. 4It is difficult to trust the recommendations of healthcare policy makers or medical “experts”. The financial conflicts of interest are extensive and well reported. 5The FDA does not know all the chemicals in our food. 6Drug companies spend heavily to market more drugs, for higher prices, and for longer periods to time to Americans. (In 2023 advertisements from drug makers accounted for half of the ad spending on five popular nightly news shows.) 7A significant number of clinical trials supporting FDA drug approvals had limitations in their design or execution, affecting reproducibility. For example, a 2012 analysis attempted to replicate 53 landmark cancer studies but succeeded in confirming the original results in only 11% of them. 815% of hospital activity and expenditure in OECD countries is a direct result of adverse events. 9This Is Leading To Major Political ConsequencesIt is not surprising that healthcare was a major – and for many Americans the major – issue in recent national elections. 10 As a result, the election outcomes will significantly impact U.S. health policy. 11Patients and physicians alike are demanding better access to trustworthy information, a sharp reduction in unnecessary costs, and policies based on science and common sense rather than on corporate profit. It is now a national governmental imperative to meet these demands.RegenMed Is Well Positioned To Capitalize On These Tectonic Shifts In Healthcare DeliverySolving these fundamental problems begins with unbiased datasets built from the bottom up by independent physicians, and not from the top down by conflicted policymakers and “experts.” Datasets which are clinically relevant to more patients. Datasets which deliver on the promises of “value” and “care”, rather than merely add bureaucracy. Datasets which are transparent to physicians and patients, and are independent of profit motive. Datasets which reflect and evolve on the basis of legitimate medical science and well-correlated outcomes, not the opaque motives of anonymous committees. RegenMed provides the platforms and processes to develop such datasets for any condition or protocol – efficiently and at low-cost. Its technology and processes return to physicians and their patients the power to identify what they, and not drug companies and conflicted “experts”, believe are the diagnoses and treatment protocols most likely to lead to better and cost-effective outcomes. And RegenMed is not stopping there. For example, it is now working on a powerful AI layer which will enable efficient querying of any or all of its datasets. Because of the high-quality of these datasets, we believe that such queries will provide reliable support for everyday clinical decision-making. This is in stark contrast to the AI “hallucinations” and other artifacts of highly manipulated “big data”.